IO Biotech Inc Working Capital to Net Assets Ratio

Latest as of September 2025: 2032.9%

IO Biotech Inc working capital to net assets ratio. IO Biotech Inc (IOBT) has a Working Capital to Net Assets ratio of 2032.9% as of September 2025. Working capital of $18.52 Million (current assets of $36.83 Million minus current liabilities of $18.31 Million) is measured against net assets of $911.00K. A higher ratio indicates strong short-term liquidity financed by the equity base. Check IOBT tangible net assets ratio to evaluate the tangible quality of the company's equity base.

WC/NA Ratio

2032.9%
Working Capital / Net Assets

Working Capital

$18.52 Million
USD

Current Assets

$36.83 Million
USD

Current Liabilities

$18.31 Million
USD

Working Capital to Net Assets Ratio of IO Biotech Inc (2019–2024)

Working capital to net assets ratio of IO Biotech Inc from 2019 to 2024. This chart shows how IO Biotech Inc's Working Capital to Net Assets ratio has evolved across 6 annual periods from 2019 to 2024. As of September 2025, the ratio stands at 2032.9%, reflecting working capital of $18.52 Million against net assets of $911.00K USD. See defensive interval ratio of IO Biotech Inc to measure how many days the company can operate on defensive assets alone.

IO Biotech Inc Working Capital to Net Assets Ratio by Year (2019–2024)

IO Biotech Inc working capital to net assets ratio by year from 2019 to 2024. The table below presents the year-by-year Working Capital to Net Assets ratio for IO Biotech Inc from 2019 to 2024, covering 6 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see IOBT total asset value.

Year WC/NA Ratio Working Capital (USD) Net Assets Current Assets Current Liabilities Change (pp)
2024 96.7% $45.47 Million $47.02 Million $64.95 Million $19.49 Million ▼ -2.1 pp
2023 98.8% $131.54 Million $133.16 Million $147.25 Million $15.72 Million ▼ -0.3 pp
2022 99.1% $137.54 Million $138.85 Million $148.22 Million $10.68 Million ▼ -0.7 pp
2021 99.8% $211.43 Million $211.92 Million $221.74 Million $10.30 Million ▲ +0.5 pp
2020 99.3% $2.58 Million $2.60 Million $5.63 Million $3.05 Million ▲ +1.5 pp
2019 97.8% $-1.44 Million $-1.47 Million $9.40 Million $10.84 Million —
pp = percentage points